Table 3.
Treatment-emergent adverse events with ≥5% incidence rate for patients treated with duloxetine
| Event, n (%) | Placebo | Duloxetine | p-value |
|---|---|---|---|
| N = 140 | N = 151 | ||
| Any event | 71 (50.7) | 91 (60.3) | 0.125 |
| Nausea | 9 (6.4) | 17 (11.3) | 0.157 |
| Headache | 9 (6.4) | 16 (10.6) | 0.218 |
| Constipation | 5 (3.6) | 14 (9.3) | 0.059 |
| Dizziness | 10 (7.1) | 12 (7.9) | 0.828 |
| Dry mouth | 2 (1.4) | 11 (7.3) | 0.021 |
| Somnolence | 3 (2.1) | 9 (6.0) | 0.141 |